Paper41708804
Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report.
Wang X and 8 others. Ann Hematol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report. Papers, record 41708804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41708804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epstein-Barr Virus Infections | Major topic |
| Germ-Line Mutation | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Unrelated Donors | Major topic |
| Adult | |
| Female | |
| Humans | |
| Graft vs Host Disease | |
| Herpesvirus 4, Human | |
| Killer Cells, Natural | |
| Lymphohistiocytosis, Hemophagocytic |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82300226 | the National Natural Science Foundation of China | PubMed | ||
| 82170223 | the National Natural Science Foundation of China | PubMed | ||
| 2024AFD421 | the Natural Science Foundation of Hubei Province | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36461028 | Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT. | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/36461028 | PubMed |
| 2 | 17550855 | Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients. | Haematologica | 2007 | https://conductscience.org/library/papers/17550855 | PubMed |
| 3 | 37313400 | Combined immunodeficiency caused by pathogenic variants in the ZAP70 C-terminal SH2 domain. | Front Immunol | 2023 | https://conductscience.org/library/papers/37313400 | PubMed |
| 4 | 36476521 | Chronic Active Epstein-Barr Virus Infection With Central Nervous System Involvement in Children: A Clinical Study of 22 Cases. | Pediatr Infect Dis J | 2023 | https://conductscience.org/library/papers/36476521 | PubMed |
| 5 | 18419486 | Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18419486 | PubMed |
| 6 | 10995743 | Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10995743 | PubMed |
| 7 | 37728704 | Updated guidelines for chronic active Epstein-Barr virus disease. | Int J Hematol | 2023 | https://conductscience.org/library/papers/37728704 | PubMed |
| 8 | 22520844 | The JAK-STAT pathway at twenty. | Immunity | 2012 | https://conductscience.org/library/papers/22520844 | PubMed |
| 9 | 8627172 | Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. | J Exp Med | 1996 | https://conductscience.org/library/papers/8627172 | PubMed |
| 10 | 27621731 | NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection. | Front Immunol | 2016 | https://conductscience.org/library/papers/27621731 | PubMed |
| 11 | 32213613 | Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation. | J Virol | 2020 | https://conductscience.org/library/papers/32213613 | PubMed |
| 12 | 33420394 | Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/33420394 | PubMed |
| 13 | 38502913 | A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry. | Ann Med | 2024 | https://conductscience.org/library/papers/38502913 | PubMed |
| 14 | 34670275 | High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. | Blood Adv | 2022 | https://conductscience.org/library/papers/34670275 | PubMed |
| 15 | 39932888 | Sex Differences in Anti-Epstein-Barr Virus Antibody Responses. | J Infect Dis | 2025 | https://conductscience.org/library/papers/39932888 | PubMed |
| 16 | 32386415 | Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 Pathways. | J Infect Dis | 2020 | https://conductscience.org/library/papers/32386415 | PubMed |
| 17 | 36423698 | Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases. | J Allergy Clin Immunol | 2023 | https://conductscience.org/library/papers/36423698 | PubMed |
| 18 | 29684201 | Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29684201 | PubMed |
| 19 | 22096243 | EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. | Blood | 2012 | https://conductscience.org/library/papers/22096243 | PubMed |
| 20 | 21454450 | Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. | Blood | 2011 | https://conductscience.org/library/papers/21454450 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41708804
GET https://conductscience.org/api/papers/v1/41708804/references?page=2